Search Within

The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer

Journal: Current Pharmaceutical Biotechnology
Volume: 16,Issue: 9
Page: 804-815
Authors: Andrea Nicolini, Paola Ferrari, Lucie Kotlarova, Giuseppe Rossi and Pier M. Biava

Immunotherapy and Hormone-therapy in Metastatic Breast Cancer: A Review and an Update

Journal: Current Drug Targets
Volume: 17,Issue: 10
Page: 1127-1139
Authors: Andrea Nicolini, Angelo Carpi, Paola Ferrari, Pier Mario Biava and Giuseppe Rossi

Classical and Non-Classical Thyroid Hormone Intracellular Pathways Involved in T Lymphoma Growth

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 37-42
Authors: Maria L.B. Arcos, Helena Sterle, Florencia Cayrol, Maria C.D. Flaque, Eduardo Valli, Maria A. Paulazo, Alicia J. Klecha and Graciela A. Cremaschi

Early Docetaxel and Androgen Deprivation in the Treatment of Metastatic, Hormone-sensitive Prostate Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 11,Issue: 4
Page: 317-323
Authors: Davide Tassinari, Emiliano Tamburini, Lorenzo Gianni, Fabrizio Drudi, Manuela Fantini, Carlotta Santelmo, Lucia Stocchi, Francesco Montanari and Sergio Sartori

Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer

Journal: Medicinal Chemistry
Volume: 12,Issue: 3
Page: 261-267
Authors: Franco Lumachi, Davide A. Santeufemia, Giovanni M. Fadda, Renato Tozzoli, Giordano B. Chiara and Stefano M.M. Basso

Stress Hormone-Mediated DNA Damage Response -- Implications for Cellular Senescence and Tumour Progression

Journal: Current Drug Targets
Volume: 17,Issue: 4
Page: 398-404
Authors: María Moreno-Villanueva and Alexander Bürkle

New Ways to Improve Breast Cancer Therapy Targeting Specific Molecular Pathways

Journal: Current Cancer Therapy Reviews
Volume: 11,Issue: 4
Page: 222-259
Authors: John P. Schwerkoske and Douglas Yee

Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers

Journal: Current Molecular Pharmacology
Volume: 10,Issue: 2
Page: 86-114
Authors: Pooneh Mokarram, Javad Alizadeh, Vahid Razban, Mahdi Barazeh, Claudia Solomon and Soudabeh Kavousipour

Thyroid Hormones Crosstalk with Growth Factors: Old Facts and New Hypotheses

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 71-85
Authors: Elena Candelotti, Paolo De Vito, Ragab G. Ahmed, Paolo Luly, Paul J. Davis, Jens Z. Pedersen, Hung-Yun Lin and Sandra Incerpi

Stroke and Neuroinflamation: Role of Sexual Hormones

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 10
Page: 1334-1349
Authors: Maria Jose Perez-Alvarez and Francisco Wandosell

Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease

Journal: Current Molecular Pharmacology
Volume: 9,Issue: 2
Page: 109-125
Authors: Naihsuan C. Guy, Yenni A. Garcia and Marc B. Cox

Anti-Hormonal Therapies for Premenopausal Patients – What did we Learn from the TEXT/SOFT Trials?

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 2
Page: 90-100
Authors: Matias E. Valsecchi, Gonzalo Recondo, Maximo de la Vega, Martin Greco, Gonzalo Recondo and Enrique Diaz Canton

Role of microRNA in Regulating Cell Signaling Pathways, Cell Cycle, and Apoptosis in Non-Small Cell Lung Cancer

Journal: Current Molecular Medicine
Volume: 16,Issue: 5
Page: 474-486
Authors: D.K. Singh, S. Bose and S. Kumar

Harmine Induces Gastric Cancer Cell Apoptosis through the ROSmediated PI3K/AKT Signaling Pathway

Journal: Current Signal Transduction Therapy
Volume: 10,Issue: 2
Page: 112-118
Authors: Qingqing Ding, Zhuoyun Wang, Ke Ma and Qi Chen

Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy

Journal: Current Drug Targets
Volume: 17,Issue: 8
Page: 853-864
Authors: Zhiyu Wang, Pengxi Liu, Qianjun Chen, Shigui Deng, Xiaoyan Liu, Honglin Situ, Shaowen Zhong, Swei Hann and Yi Lin

Previous     Next

Go To   Results 1 - 15 of 2905